Daniel W. Muehl
2020 - Clovis Oncology
In 2020, Daniel W. Muehl earned a total compensation of $1.3M as EVP and Chief Financial Officer at Clovis Oncology, a 63% decrease compared to previous year.
Compensation breakdown
| Bonus | $229,158 |
|---|---|
| Salary | $468,851 |
| Stock Awards | $613,460 |
| Other | $21,969 |
| Total | $1,333,438 |
Muehl received $613.5K in stock awards, accounting for 46% of the total pay in 2020.
Muehl also received $229.2K in bonus, $468.9K in salary and $22K in other compensation.
Rankings
In 2020, Daniel W. Muehl's compensation ranked 7,366th out of 13,090 executives tracked by ExecPay. In other words, Muehl earned more than 43.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,366 out of 13,090 | 44th |
Division Manufacturing | 3,090 out of 5,621 | 45th |
Major group Chemicals And Allied Products | 1,246 out of 2,254 | 45th |
Industry group Drugs | 1,075 out of 1,954 | 45th |
Industry Pharmaceutical Preparations | 804 out of 1,459 | 45th |
Pay ratio
| Daniel W. Muehl's Pay | $1,333,438 |
|---|---|
| Median Employee's Pay | $230,943 |
| Pay Ratio | 6to 1 |
In 2020, the annual total compensation of Daniel W. Muehl was $1,333,438.
The annual total compensation of the median employee at Clovis Oncology was $230,943.
The ratio of Daniel W. Muehl's pay to the pay of median employee was therefore 6 to one.
Source: SEC filing on April 28, 2021.
Muehl's colleagues
We found four more compensation records of executives who worked with Daniel W. Muehl at Clovis Oncology in 2020.
News
Clovis Oncology CEO Patrick Mahaffy's 2021 pay slips 18% to $2.6M
April 27, 2022
Clovis Oncology CEO Patrick Mahaffy's 2020 pay falls 53% to $3.2M
April 28, 2021
Clovis Oncology CEO Patrick Mahaffy's 2019 pay rises 10% to $6.9M
April 24, 2020
Clovis Oncology CEO Patrick Mahaffy's 2018 pay falls 28% to $6.3M
April 26, 2019